ELAB · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 34 employees
116
SEC Filings
$1.92
Close 2026-05-28
34
Employees
Business Summary
PART I Overview As of December 31, 2025, we manage and operate a diverse portfolio of four (4) wholly owned subsidiaries across the medical aesthetics and biopharmaceutical sectors: Northstrive Biosciences Inc. (Northstrive Biosciences) is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. Our lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesitys pressing issue of pres...
Latest Stock Quote
ELAB 2026-05-28 $1.92
O:$1.72 H:$1.92 L:$1.65 Vol:9.6M VWAP:$2.1918